Cardiometabolic & kidney

Changes in Cardiovascular Health at Midlife and Subsequent Cardiovascular Outcomes in Individuals With Diabetes

JACC AdvPublished Prospective cohort study

Authors' conclusion

For patients with diabetes, achieving or maintaining ideal CVH levels at midlife may help improve outcome; however, CVD risk is not completely mitigated by favorable CVH trajectories.

Study context

Population
Midlife adults with and without diabetes, ARIC Study; median follow-up 23 years806 with diabetes (9.2%)
Participants
8,741 adults
Exposure
Change in cardiovascular health (CVH) between visits 1 and 3 in individuals with diabetes
Outcome
CVD events and all-cause mortality
Follow-up
Median 23 years
Methodological detailsAtherosclerosis Risk in Communities Study, Cox proportional hazards regression
  • Atherosclerosis Risk in Communities Study
  • Cox proportional hazards regression

Main finding

As reported in the abstract

CVD events (individuals with diabetes)
Reference group not stated
Hazard ratio (95% CI)
Improved CVH
0.69(0.50–0.93)
Maintained moderate CVH
0.68(0.50–0.94)
Moderate to low CVH
0.60(0.41–0.88)

Observational data: associations, not effects.

Further findings

All-cause mortality (individuals with diabetes)

Similar patterns as for cardiovascular disease (CVD) events

CVD events and mortality, diabetes vs no diabetes with maintained favorable CVH

Those with diabetes consistently had higher risks regardless of CVH trajectory

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Changes in Cardiovascular Health at Midlife and Subsequent Cardiovascular Outcomes in Individuals With Diabetes. JACC Adv. Published 16 December 2024. doi:10.1016/j.jacadv.2024.101450

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.